Details for New Drug Application (NDA): 090134
✉ Email this page to a colleague
The generic ingredient in DOXYCYCLINE HYCLATE is doxycycline hyclate. There are twenty-eight drug master file entries for this compound. Seventy-two suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
Summary for 090134
Tradename: | DOXYCYCLINE HYCLATE |
Applicant: | Actavis Elizabeth |
Ingredient: | doxycycline hyclate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 090134
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DOXYCYCLINE HYCLATE | doxycycline hyclate | TABLET, DELAYED RELEASE;ORAL | 090134 | ANDA | Actavis Pharma, Inc. | 0591-4550 | 0591-4550-22 | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (0591-4550-22) |
DOXYCYCLINE HYCLATE | doxycycline hyclate | TABLET, DELAYED RELEASE;ORAL | 090134 | ANDA | Actavis Pharma, Inc. | 0591-4575 | 0591-4575-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (0591-4575-60) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 75MG BASE | ||||
Approval Date: | Dec 14, 2011 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 100MG BASE | ||||
Approval Date: | Dec 14, 2011 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 50MG BASE | ||||
Approval Date: | May 22, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription